How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
Glucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes,...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/1/216 |
_version_ | 1827665943057137664 |
---|---|
author | Carmen Sorina Martin Ovidiu Dumitru Parfeni Liliana Gabriela Popa Mara Madalina Mihai Dana Terzea Vlad Herlea Mirela Gherghe Razvan Adam Osama Alnuaimi Valentin Calu Adrian Miron Silvius Negoita Cornelia Nitipir Simona Fica |
author_facet | Carmen Sorina Martin Ovidiu Dumitru Parfeni Liliana Gabriela Popa Mara Madalina Mihai Dana Terzea Vlad Herlea Mirela Gherghe Razvan Adam Osama Alnuaimi Valentin Calu Adrian Miron Silvius Negoita Cornelia Nitipir Simona Fica |
author_sort | Carmen Sorina Martin |
collection | DOAJ |
description | Glucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes, diarrhea, deep vein thrombosis, weight loss, and depression. Here, we report the case of a 44-year-old male with a history of diabetes mellitus, presenting with a pruritic and painful disseminated cutaneous eruption of erythematous plaques, with scales and peripheral pustules, misdiagnosed as disseminated pustular psoriasis and treated for 2 years with oral retinoid and glucocorticoids. During this period, the patient complained of weight loss of 32 kg and diarrhea and developed deep vein thrombosis. These symptoms, together with an inadequate response to therapy of the skin lesions, led to the reassessment of the initial diagnosis. Laboratory tests confirmed elevated plasma glucagon levels (>1000 pg/mL) and computed tomography (CT) scans revealed a 35/44 mm tumor in the pancreatic tail. Due to considerable disease complications and the COVID-19 pandemic, the surgical removal of the tumor was delayed for nearly 2 years. During this time, somatostatin analogue therapy efficiently controlled the glucagonoma syndrome and likely prevented tumor progression. As in other functional pancreatic NETs, the early clinical recognition of hormonal hypersecretion syndrome and the multidisciplinary approach are the keys for best patient management. |
first_indexed | 2024-03-10T01:37:06Z |
format | Article |
id | doaj.art-09b9792092184d8a9f7754b945b65c09 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-03-10T01:37:06Z |
publishDate | 2022-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-09b9792092184d8a9f7754b945b65c092023-11-23T13:30:15ZengMDPI AGDiagnostics2075-44182022-01-0112121610.3390/diagnostics12010216How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?Carmen Sorina Martin0Ovidiu Dumitru Parfeni1Liliana Gabriela Popa2Mara Madalina Mihai3Dana Terzea4Vlad Herlea5Mirela Gherghe6Razvan Adam7Osama Alnuaimi8Valentin Calu9Adrian Miron10Silvius Negoita11Cornelia Nitipir12Simona Fica13Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, RomaniaDepartment of Oncological Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Oncological Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaOncoTeam Diagnostic, 030138 Bucharest, RomaniaDepartment of Pathology, Fundeni Clinical Institute, 022328 Bucharest, RomaniaDepartment of Radiology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Firs Aid and Disaster Medicine, Titu Maiorescu University, 040051 Bucharest, RomaniaDepartment of Radiology, Elias Emergency University Hospital, 011461 Bucharest, RomaniaDepartment of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Anaesthesia and Intensive Care, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Oncology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaGlucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes, diarrhea, deep vein thrombosis, weight loss, and depression. Here, we report the case of a 44-year-old male with a history of diabetes mellitus, presenting with a pruritic and painful disseminated cutaneous eruption of erythematous plaques, with scales and peripheral pustules, misdiagnosed as disseminated pustular psoriasis and treated for 2 years with oral retinoid and glucocorticoids. During this period, the patient complained of weight loss of 32 kg and diarrhea and developed deep vein thrombosis. These symptoms, together with an inadequate response to therapy of the skin lesions, led to the reassessment of the initial diagnosis. Laboratory tests confirmed elevated plasma glucagon levels (>1000 pg/mL) and computed tomography (CT) scans revealed a 35/44 mm tumor in the pancreatic tail. Due to considerable disease complications and the COVID-19 pandemic, the surgical removal of the tumor was delayed for nearly 2 years. During this time, somatostatin analogue therapy efficiently controlled the glucagonoma syndrome and likely prevented tumor progression. As in other functional pancreatic NETs, the early clinical recognition of hormonal hypersecretion syndrome and the multidisciplinary approach are the keys for best patient management.https://www.mdpi.com/2075-4418/12/1/216neuroendocrine tumorglucagonglucagonomasomatostatin analoguesnecrolytic migratory erythema |
spellingShingle | Carmen Sorina Martin Ovidiu Dumitru Parfeni Liliana Gabriela Popa Mara Madalina Mihai Dana Terzea Vlad Herlea Mirela Gherghe Razvan Adam Osama Alnuaimi Valentin Calu Adrian Miron Silvius Negoita Cornelia Nitipir Simona Fica How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? Diagnostics neuroendocrine tumor glucagon glucagonoma somatostatin analogues necrolytic migratory erythema |
title | How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? |
title_full | How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? |
title_fullStr | How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? |
title_full_unstemmed | How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? |
title_short | How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma? |
title_sort | how many times can one go back to the drawing board before the accurate diagnosis and surgical treatment of glucagonoma |
topic | neuroendocrine tumor glucagon glucagonoma somatostatin analogues necrolytic migratory erythema |
url | https://www.mdpi.com/2075-4418/12/1/216 |
work_keys_str_mv | AT carmensorinamartin howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT ovidiudumitruparfeni howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT lilianagabrielapopa howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT maramadalinamihai howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT danaterzea howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT vladherlea howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT mirelagherghe howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT razvanadam howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT osamaalnuaimi howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT valentincalu howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT adrianmiron howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT silviusnegoita howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT cornelianitipir howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma AT simonafica howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma |